The global glycated haemoglobin testing market is dominated by the glucose monitoring devices segment which contributed around three-fourths of the total market share in 2019. This type of devices helps diabetics in monitoring their blood glucose levels at home and assists physicians in determining the efficacy of treatment. The increase in the number of patients with diabetes worldwide is a key factor driving the demand for glucose monitoring devices and test strips. With rising awareness regarding diabetes management, the adoption of self-monitoring blood glucose devices has increased significantly over the years.
The glycated haemoglobin testing market is estimated to be valued at USD 239 Mn in 2024 and is expected to reach USD 426 Mn by 2031, growing at a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.
Key Takeaways Key players operating in the glycated haemoglobin testing market are Abbott Laboratories, Thermo Fisher Scientific Inc., Arkray Inc., Bio-Rad Laboratories Inc., Danaher Corporation (Beckman Coulter), F. Hoffmann-La Roche AG, and EKF Diagnostics Holdings plc.
The increasing incidence of diabetes and rising awareness regarding diabetes management offer lucrative growth opportunities for players in the Glycated Haemoglobin Testing Market. According to the International Diabetes Federation, around 463 million adults aged between 20-79 years were diagnosed with diabetes globally in 2019 and this number is projected to reach 700 million by 2045.
Extensive research in the field of diabetes treatment and development of novel monitoring devices can help companies expand their share in the global market. Major players are expanding their presence in emerging nations through acquisitions and collaborations with regional players. For instance, in 2021, Abbott acquired a majority stake in Quotient Limited which is engaged in the development and commercialization of transfusion diagnostics. This strengthened Abbott's position in Asia-Pacific and emerging markets.
Market Drivers
- Rising diabetes prevalence worldwide driven by obesity, sedentary lifestyle and unhealthy diet is a major factor fueling demand for glycated haemoglobin testing.
- Growing geriatric population prone to diabetes is driving the need for regular monitoring and management of blood glucose levels.
- Increasing adoption of personal glucose monitoring devices for self-care and remote monitoring is boosting the market growth.
Market Restraints
- High price of glucose monitoring systems hampers its adoption in low and middle-income countries.
- Reimbursement concerns regarding diabetes care devices and lack of awareness in developing nations are restraining factors.
- Frequent calibration requirements and inconveniences associated with finger pricking may discourage some patients from opting for self-monitoring.
Segment Analysis
The global glycated haemoglobin testing market is segmented into hospitals, diagnostics laboratories, and others. The hospitals segment dominates the market owing to increasing cases of diabetes, availability of advanced diagnostic technologies, and routine health checkups. Hospitals provide advanced treatment options for diabetes management. Furthermore, increasing healthcare expenditure and availability of favorable reimbursement policies in hospital settings drive the segment's growth. The diagnostics laboratories segment will gain traction during the forecast period. This is attributed to rising awareness regarding early diabetes diagnosis, presence of leading players, and increasing number of labs equipped with advanced analytical instruments for glycated haemoglobin testing. Diagnostics labs offer affordable tests to the masses, promoting the segment's outlook.
Global Analysis
North America dominates the global market and will continue its dominance during the forecast period. The rising prevalence of diabetes, increasing healthcare spending, availability of advanced healthcare infrastructure, presence of global market leaders, and favorable reimbursement policies support the region's largest share. Asia Pacific will emerge as the fastest-growing regional market from 2024 to 2031. The growth can be attributes to growing medical tourism, rising disposable incomes, increasing healthcare awareness, expanding diagnostics industry and improving access to healthcare services in emerging economies such as India and China.
Get this Report in Japanese Language: 糖化ヘモグロビン検査市場
Get this Report in Korean Language: 당화 헤모글로빈 검사 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
The new report by Expert Market Research titled, ‘Global Glycated Haemoglobin Testing Market Report and Forecast 2021-2026’, gives in-depth analysis of the global glycated haemoglobin testing market, assessing the market based on its segments like product type, technology, end-use, and major regions.
The sample report shall be delivered to you within 24 hours.Request a free sample copy in PDF or view the report summary@ https://www.expertmarketresearch.com/reports/glycated-haemoglobin-testing-market/requestsampleThe key highlights of the report include:Market Overview:Forecast CAGR (2021-2026): 9%Growing diabetic patients, increasing geriatric population, technical developments in diagnosing diabetes, growth in the home healthcare industry, and increased early detection R activities and successful disease management are the key factors contributing to the growth of the glycated haemoglobin testing market.
However, the market development is likely to be hampered by the existence of alternatives and high costs associated with glycated haemoglobin research.
In developing countries, an increase in the diabetic population and rising awareness of POC HbA1c testing are expected to fuel market growth soon.Explore the full report with the table of contents@ https://www.expertmarketresearch.com/reports/glycated-haemoglobin-testing-marketIndustry Definition and Major SegmentsTo calculate the three-month average plasma glucose concentration, glycated haemoglobin is used.
It is a standardised test that demonstrates the amount of HbA1c, a specific type of glycated haemoglobin, in the blood of individuals during the past two to four months.
The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.Read More Reports:-Global Motion Sensor Market: https://www.expertmarketresearch.com/reports/motion-sensor-marketGlobal Moulded Pulp Packaging Market: https://www.expertmarketresearch.com/reports/molded-pulp-packaging-marketGlobal Mould Release Agents Market: https://www.expertmarketresearch.com/reports/mold-release-agents-marketGlobal Lung Stent Market: https://www.expertmarketresearch.com/reports/lung-stent-marketJapanese Encephalitis Vaccine Market: https://www.expertmarketresearch.com/reports/japanese-encephalitis-vaccine-marketGlobal Instrument Transformer Market: https://www.expertmarketresearch.com/reports/instrument-transformer-marketGlobal HPV Associated Disorders Market: https://www.expertmarketresearch.com/reports/hpv-associated-disorders-marketGlobal Hot Runner Market: https://www.expertmarketresearch.com/reports/hot-runner-marketGlobal Hormonal Contraceptive Market: https://www.expertmarketresearch.com/reports/hormonal-contraceptive-marketGlobal Homecare Ventilator Market: https://www.expertmarketresearch.com/reports/homecare-ventilator-marketNote 2: As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours.
Driving producers of restorative gadgets are expected to be enter in the worldwide rise of the glycated hemoglobin testing market.
Organizations specifically, Bio-Rad Laboratories, Bayer, Arkray, Chek Diagnostics, Diazyme Laboratories, X Lite-On Technology, TaiDoc Technology, Trinity Biotech, Siemens Healthcare, Ceragem Medisys, Tosoh Bioscience, DiaSys Diagnostic Systems, Erba Mannheim, Daiichi Biotech, Human Diagnostics, EKF Diagnostics, Mindray Medical, Sebia, and Randox Laboratories are relied upon to be seen as driving producers of gadgets utilized as a part of glycated hemoglobin tests.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=35429 As indicated in a report by Transparency Market Research (TMR), the worldwide market for glycated hemoglobin testing is anticipated to be somewhere worth US$ 705 mn before the year 2026.
The worldwide glycated hemoglobin testing market, North America is relied upon to command as far as worldwide revenue share.
Additionally, the utilization of these procedures will depend mainly upon the end-utilization of glycated hemoglobin tests.Request COVID Analysis on Glycated Hemoglobin Testing Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=35429 Point-of-care Segment to Dominate the Other Test Segments in the Global MarketPatients looking for glycated hemoglobin testing are developing more slant towards research center based tests.
While point-of-care glycated hemoglobin testing is comparatively more advantageous choice, the outcomes and symptomatic results of research facilities keep on spearheading their strength in the worldwide market.
The report additionally uncovers that healing facilities are likely to be the biggest end-clients of glycated hemoglobin testing in the worldwide market.
The global Glycated Albumin Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the glycated albumin market include Asahi Kasei Pharma Corporation, Lifespan Biosciences, Inc., Biomatik Corporation, Abbexa Ltd., G-Biosciences, DRG International, Inc., msbio LLC, Signalway Antibody LLC, United States Biological Corp., Diazyme Laboratories, and Abnova Corporation.
This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Glycated Albumin Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/glycated-albumin-market/download-sampleMarket DynamicsAn escalating number of people diagnosed with diabetes mellitus every year, rising need to prevent and treat hyperglycemia, and growing need to control blood glucose levels are key factors anticipated to support glycated albumin market growth.
Another factor driving the glycated albumin market is that companies emphasize developing new and improved glycated albumin products.
Furthermore, fast approvals for new glycated albumin kits and launching the same, giving a competitive edge to firms, will also positively impact the glycated albumin market during the forecast period.
